Stay updated on Nivolumab for Squamous Dysplasia Reversal Clinical Trial
Sign up to get notified when there's something new on the Nivolumab for Squamous Dysplasia Reversal Clinical Trial page.

Latest updates to the Nivolumab for Squamous Dysplasia Reversal Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe webpage has been updated to reflect a new version of a clinical study involving the PD-1 inhibitor nivolumab, with changes in the principal investigator's name and the revision number. Additionally, the study's design details have been streamlined, removing some specific procedural information.SummaryDifference45%
- Check29 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check87 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
- Check94 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.1%
Stay in the know with updates to Nivolumab for Squamous Dysplasia Reversal Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab for Squamous Dysplasia Reversal Clinical Trial page.